Specifically, we confirmed that the low levels of DOK7 were related to bad clinical outcomes and poor prognosis of patients with breast cancer; therefore, DOK7 had a potential value as a molecular biomarker in prognosis prediction of breast cancer. Here, DOK7 is linked to breast carcinoma.